Compass Therapeutics, Inc. (CMPX) vs Foghorn Therapeutics Inc. (FHTX)
Compass Therapeutics, Inc. and Foghorn Therapeutics Inc. are both Biotechnology companies. Compass Therapeutics, Inc. and Foghorn Therapeutics Inc. are of similar size ($213.8M and $205.3M). Compass Therapeutics, Inc. has the higher net margin (0.00% vs −175.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Foghorn Therapeutics Inc. leads on 6 and Compass Therapeutics, Inc. on 5.
Valuation
Profitability
| Metric | CMPX | FHTX | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | (198.04%) | 0.00% |
| Net margin | 0.00% | (175.78%) | 0.00% |
| Free cash flow margin | 0.00% | (229.49%) | 0.00% |
| Return on equity | (56.66%) | 81.90% | (57.72%) |
| Return on assets | (47.87%) | (30.06%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack